ATE375164T1 - Endotoxin-bindung durch milchsäurebakterien und bifidobacteria - Google Patents

Endotoxin-bindung durch milchsäurebakterien und bifidobacteria

Info

Publication number: ATE375164T1
Authority: AT; Austria
Prior art keywords: bifidobacteria; lactic acid; acid bacteria; endotoxin binding; endotoxin
Prior art date: 2001-02-06

Application number

AT02719762T

Other languages

English (en)

Inventor

Eduardo Schiffrin

Guillermo Kociubinski

Original Assignee

Nestle Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-06

Filing date

2002-02-01

Publication date

2007-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179863&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE375164(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-02-01 Application filed by Nestle Sa filed Critical Nestle Sa

2007-10-15 Application granted granted Critical

2007-10-15 Publication of ATE375164T1 publication Critical patent/ATE375164T1/de

Links

JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 4
241000894006 Bacteria Species 0.000 title abstract 2
241000186000 Bifidobacterium Species 0.000 title abstract 2
235000014655 lactic acid Nutrition 0.000 title abstract 2
239000004310 lactic acid Substances 0.000 title abstract 2
108010072542 endotoxin binding proteins Proteins 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
239000002158 endotoxin Substances 0.000 abstract 1
230000005661 hydrophobic surface Effects 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/854—Lactobacillus acidophilus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Microbiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Immunology (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Feed For Specific Animals (AREA)
Fodder In General (AREA)

AT02719762T 2001-02-06 2002-02-01 Endotoxin-bindung durch milchsäurebakterien und bifidobacteria ATE375164T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01200436		2001-02-06

Publications (1)

Publication Number	Publication Date
ATE375164T1 true ATE375164T1 (de)	2007-10-15

Family

ID=8179863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02719762T ATE375164T1 (de)	2001-02-06	2002-02-01	Endotoxin-bindung durch milchsäurebakterien und bifidobacteria

Country Status (20)

Country	Link
US (2)	US7550285B2 (de)
EP (1)	EP1359924B1 (de)
JP (3)	JP2004531477A (de)
KR (1)	KR100845456B1 (de)
CN (1)	CN1250232C (de)
AT (1)	ATE375164T1 (de)
AU (1)	AU2002250886B2 (de)
BR (1)	BR0207019A (de)
CA (1)	CA2436264C (de)
DE (1)	DE60222856T2 (de)
EA (1)	EA006397B1 (de)
ES (1)	ES2292744T3 (de)
IL (1)	IL157071A0 (de)
MX (1)	MXPA03007024A (de)
NO (1)	NO20033372L (de)
NZ (1)	NZ527493A (de)
PL (1)	PL367083A1 (de)
PT (1)	PT1359924E (de)
WO (1)	WO2002062360A1 (de)
ZA (1)	ZA200306935B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002062360A1 (en) *	2001-02-06	2002-08-15	Societe Des Produits Nestle S.A.	Endotoxin binding by lactic acid bacteria and bifidobacteria
FR2848115B1 (fr) *	2002-12-05	2005-03-25	Rhodia Chimie Sa	Composition de bacteries et son utilisation
SE526711C2 (sv)	2003-01-31	2005-10-25	Probi Ab	Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
US20050158294A1 (en)	2003-12-19	2005-07-21	The Procter & Gamble Company	Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en)	2003-12-19	2014-11-04	The Iams Company	Methods of use of probiotic bifidobacteria for companion animals
US7862808B2 (en) *	2004-07-01	2011-01-04	Mead Johnson Nutrition Company	Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7303745B2 (en) *	2005-04-15	2007-12-04	Bristol-Myers Squibb Company	Method for preventing or treating the development of respiratory allergies
EP2261323A1 (de)	2005-05-31	2010-12-15	The Iams Company	Probiotische Katzen-Laktobazillen
AU2006253007B2 (en)	2005-05-31	2012-12-20	Alimentary Health Ltd	Feline probiotic Bifidobacteria
US20090083067A1 (en) *	2006-03-29	2009-03-26	Mary Elaine Freeland	Methods and kits for selecting a health care product
RU2436581C2 (ru)	2007-02-01	2011-12-20	Дзе Иамс Компани	Способ уменьшения воспаления и снижения стресса у млекопитающего
CN105796607A (zh) *	2007-02-28	2016-07-27	Mjn 美国控股有限责任公司	用于儿童或婴幼儿的含有灭活益生菌的产品
KR100913406B1 (ko) *	2008-03-25	2009-08-21	광주과학기술원	Ｔｈ１－매개 면역 질환의 예방 또는 치료용 조성물
US9771199B2 (en) *	2008-07-07	2017-09-26	Mars, Incorporated	Probiotic supplement, process for making, and packaging
US9232813B2 (en) *	2008-07-07	2016-01-12	The Iams Company	Probiotic supplement, process for making, and packaging
EP2459203B1 (de)	2009-07-30	2018-10-31	DuPont Nutrition Biosciences ApS	Milchsäurebakterien und bifidobakterien zur behandlung von endotoxämie
US10104903B2 (en)	2009-07-31	2018-10-23	Mars, Incorporated	Animal food and its appearance
WO2011069860A1 (en)	2009-12-08	2011-06-16	Chr. Hansen A/S	Novel use for the treatment of metabolic endotoxemia
JP2010280664A (ja) *	2010-07-02	2010-12-16	Biogaia Ab	ラクトバチルス・リューテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）株を用いる哺乳類における免疫機能の改善方法
JP2014520548A (ja)	2011-07-13	2014-08-25	フリースランド・ブランズ・ビー・ブイ	低いｌｐｓを有する乳製品をベースとした組成物
US20130022586A1 (en) *	2011-07-21	2013-01-24	James Versalovic	Production and use of bacterial histamine
EP2836224A4 (de)	2012-02-29	2015-12-16	Ethicon Endo Surgery Inc	Zusammensetzungen von biozönose und zugehörige verfahren
US20150093462A1 (en) *	2013-09-30	2015-04-02	Elc Management Llc	Watery Lotion Skin Care Compositions And Methods
CA2964480A1 (en)	2014-10-31	2016-05-06	Whole Biome Inc.	Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104498375B (zh) *	2014-12-02	2017-05-10	江南大学	一株具有内毒素吸附特性的耶氏酵母及其吸附特性研究方法
JP6710075B2 (ja) *	2016-03-29	2020-06-17	カゴメ株式会社	Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
TWI640319B (zh) *	2017-05-12	2018-11-11	健茂生物科技股份有限公司	具有抗發炎活性之醱酵液的製備方法
JP2020532515A (ja)	2017-08-30	2020-11-12	ペンデュラムセラピューティクス，インコーポレイテッド	マイクロバイオーム関連障害の処置のための方法および組成物
EP3823651A4 (de)	2018-07-19	2022-04-27	Pendulum Therapeutics, Inc.	Verfahren und zusammensetzungen zur mikrobiellen transplantation
JP6888145B2 (ja) *	2020-03-23	2021-06-16	カゴメ株式会社	Ｌｐｓ産生抑制剤、及びｌｐｓ産生抑制用の食品組成物
WO2021253017A2 (en) *	2020-06-07	2021-12-16	Ramasamy Sundaram	Compositions and methods for detoxifying bacterial endotoxins and hydrogen sulfide by recombinant fusion enzymes
US20230323332A1 (en)	2020-08-28	2023-10-12	Chr. Hansen A/S	Microencapsulation of microbial culture using octenyl succinic anhydride starch-chitosan complex coacervate
CA3208064A1 (en)	2021-02-10	2022-08-18	Zhongke Wisbiom（Beijing）Biotechnology Co., Ltd.	Bifidobacterium animalis subsp. lactis and use thereof
WO2025202427A1 (en)	2024-03-28	2025-10-02	Chr. Hansen A/S	Microencapsulated microbial culture using protein-carbohydrate and chitosan complex coacervate polymer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US555618A (en) *		1896-03-03		Hay-loader
IT1254210B (it) *	1992-02-10	1995-09-14	Simone Claudio De	Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
US5413785A (en) *	1993-01-27	1995-05-09	New England Deaconess Hospital Corp.	Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
JP2506314B2 (ja) *	1993-10-27	1996-06-12	全国農業協同組合連合会	家禽・豚の敗血症の予防・治療剤及び飼料
US6506389B2 (en) *	1995-10-20	2003-01-14	Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (Tno)	Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors
DK0862863T4 (da) *	1997-01-09	2008-12-01	Nestle Sa	Kornprodukt indeholdende probiotika
JP4163276B2 (ja) *	1998-02-05	2008-10-08	独立行政法人理化学研究所	機能性組成物
US6368591B2 (en) *	1998-05-15	2002-04-09	Shanghai Sine Pharmaceutical Corporation Ltd.	Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
WO2000035465A2 (en) *	1998-12-11	2000-06-22	Urex Biotech Inc.	Oral administration of lactobacillus for the treatment and prevention of urogenital infection
WO2001070246A1 (en) *	2000-03-24	2001-09-27	Societe Des Produits Nestle S.A.	Use of lactic acid bacterium for the treatment of peritonitis
WO2002062360A1 (en) *	2001-02-06	2002-08-15	Societe Des Produits Nestle S.A.	Endotoxin binding by lactic acid bacteria and bifidobacteria

2002
- 2002-02-01 WO PCT/EP2002/001163 patent/WO2002062360A1/en not_active Ceased
- 2002-02-01 EA EA200300862A patent/EA006397B1/ru not_active IP Right Cessation
- 2002-02-01 CN CNB028078845A patent/CN1250232C/zh not_active Expired - Fee Related
- 2002-02-01 NZ NZ527493A patent/NZ527493A/en unknown
- 2002-02-01 BR BR0207019-7A patent/BR0207019A/pt not_active IP Right Cessation
- 2002-02-01 MX MXPA03007024A patent/MXPA03007024A/es active IP Right Grant
- 2002-02-01 PT PT02719762T patent/PT1359924E/pt unknown
- 2002-02-01 US US10/470,807 patent/US7550285B2/en not_active Expired - Fee Related
- 2002-02-01 KR KR1020037010275A patent/KR100845456B1/ko not_active Expired - Fee Related
- 2002-02-01 AT AT02719762T patent/ATE375164T1/de not_active IP Right Cessation
- 2002-02-01 DE DE60222856T patent/DE60222856T2/de not_active Expired - Lifetime
- 2002-02-01 CA CA2436264A patent/CA2436264C/en not_active Expired - Fee Related
- 2002-02-01 ES ES02719762T patent/ES2292744T3/es not_active Expired - Lifetime
- 2002-02-01 IL IL15707102A patent/IL157071A0/xx unknown
- 2002-02-01 AU AU2002250886A patent/AU2002250886B2/en not_active Ceased
- 2002-02-01 JP JP2002562367A patent/JP2004531477A/ja active Pending
- 2002-02-01 PL PL02367083A patent/PL367083A1/xx not_active Application Discontinuation
- 2002-02-01 EP EP02719762A patent/EP1359924B1/de not_active Revoked
2003
- 2003-07-28 NO NO20033372A patent/NO20033372L/no not_active Application Discontinuation
- 2003-09-04 ZA ZA200306935A patent/ZA200306935B/en unknown
2009
- 2009-06-19 US US12/488,293 patent/US7964384B2/en not_active Expired - Fee Related
2011
- 2011-07-20 JP JP2011158962A patent/JP5973701B2/ja not_active Expired - Fee Related
2013
- 2013-11-07 JP JP2013231191A patent/JP2014062104A/ja active Pending

Also Published As

Publication number	Publication date
US20100136662A1 (en)	2010-06-03
ES2292744T3 (es)	2008-03-16
BR0207019A (pt)	2004-02-25
JP5973701B2 (ja)	2016-08-23
DE60222856D1 (de)	2007-11-22
NO20033372D0 (no)	2003-07-28
EA200300862A1 (ru)	2003-12-25
NZ527493A (en)	2005-06-24
AU2002250886B2 (en)	2007-08-02
EP1359924A1 (de)	2003-11-12
KR100845456B1 (ko)	2008-07-10
HK1066174A1 (en)	2005-03-18
EP1359924B1 (de)	2007-10-10
NO20033372L (no)	2003-07-28
US20040115178A1 (en)	2004-06-17
IL157071A0 (en)	2004-02-08
US7550285B2 (en)	2009-06-23
DE60222856T2 (de)	2008-07-24
JP2011246483A (ja)	2011-12-08
KR20030076652A (ko)	2003-09-26
PT1359924E (pt)	2007-12-07
CA2436264A1 (en)	2002-08-15
CA2436264C (en)	2014-01-28
PL367083A1 (en)	2005-02-21
CN1501805A (zh)	2004-06-02
EA006397B1 (ru)	2005-12-29
MXPA03007024A (es)	2003-11-18
US7964384B2 (en)	2011-06-21
JP2004531477A (ja)	2004-10-14
ZA200306935B (en)	2004-12-06
JP2014062104A (ja)	2014-04-10
CN1250232C (zh)	2006-04-12
WO2002062360A1 (en)	2002-08-15

Legal Events

Date	Code	Title	Description
2008-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE375164T1 (de)	2007-10-15	Endotoxin-bindung durch milchsäurebakterien und bifidobacteria
WO2005055944A3 (en)	2007-06-28	Oligosaccharide compositions and use thereof in the treatment of infection
EP2348035A3 (de)	2011-09-14	Neue immunogene Zusammensetzungen zur Prävention und Behandlung der Meningokokken-Erkrankung
WO2007064883A3 (en)	2007-10-25	Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2006013441A3 (en)	2006-04-06	Use of probiotic bacteria for the preparation of topical compositions for skin protection
MY145077A (en)	2011-12-15	Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL147271A0 (en)	2002-08-14	Compounds that bind her2
WO2008148873A3 (en)	2009-08-20	Hydroxyproline compositions and uses thereof
WO2005089411A3 (en)	2005-12-08	Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
WO2005110445A3 (en)	2006-01-26	Methods and compositions for the dietary management of autoimmune disorders
MY148286A (en)	2013-03-29	Freeze-dried, aerated dairy or dairy-substitute compositions and methods of making thereof
PL2076271T3 (pl)	2012-02-29	Hamowanie toksyn cholery przez galaktooligosacharydy (GOS)
BR0314511A (pt)	2005-08-09	Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
EP4606428A3 (de)	2025-11-05	Heparin-assoziierte polypeptide und deren verwendungen
BR0214902A (pt)	2004-11-30	Preparação bacteriana, frações de preparação bacteriana, composição farmacêutica, uso da preparação bacteriana ou suas frações, método para a produção da preparação de bactérias mortas liofilizadas estendidas, kit para o tratamento de uma doença compreendendo uma desregulação imune, e, produtos
PT1328268E (pt)	2005-08-31	Combinacao de catequina e quercetina para utilizacao farmaceutica ou dietetica
BRPI0409609A (pt)	2006-04-18	mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
WO2006082328A3 (fr)	2006-09-28	Compositions comprenant des micro-organismes deshydrates, leurs procedes de preparation, et leurs utilisations
PL346143A1 (en)	2002-01-28	Tan-1057 derivatives
WO2009057287A1 (ja)	2009-05-07	破骨細胞形成抑制用食品素材
WO2004080373A3 (en)	2005-06-23	Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
WO2006046871A3 (en)	2006-10-19	Peri-operative composition comprising lactobacillus rhamnosus
DE60235418D1 (de)	2010-04-01	Osteoprotegerin in Milch
WO2003026693A3 (en)	2003-12-18	Inhibitors of costimulation by 0x40 and their use against infectious diseases
ATE369145T1 (de)	2007-08-15	Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen